Wotherspoon, F <br/><br/>
The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Jun 2005 
 - 697-702 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-5491.2005.01493.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bradykinin--administration & dosage<br/>Diabetes Mellitus, Type 1--physiopathology<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Forearm--blood supply<br/>Humans<br/>Male<br/>Middle Aged<br/>Nitric Oxide--physiology<br/>Prostaglandins--physiology<br/>Regional Blood Flow--drug effects<br/>Vasodilation--drug effects<br/>Vasodilator Agents--pharmacology